雅安市中药注射剂不良反应与上市后再评价  

Adverse Reaction and Revaluation Post-marketing of Traditional Medicine Injection in Ya'an

作　　者：杨勤[1] 袁勇[1] 臧云吉 饶丁[1] 何丽霞[1] 

机构地区：[1]雅安市人民医院药剂科,625000

出　　处：《内蒙古中医药》2010年第23期60-61,共2页Inner Mongolia Journal of Traditional Chinese Medicine

基　　金：雅安市(2009年度)第一批重点科技计划项目基金(编号:S0930309)

摘　　要：目的:了解中药注射剂药品不良反应(ADR)发生的特点,促进临床合理使用中药注射剂。方法:对雅安市共17家医院在2009年1～12月期间收集到的63例中药注射剂ADR报告分别从药物种类、典型病例等方面进行统计分析。结果:雅安市药品不良反应监测分中心2009年1～12月共收到777例各类药品不良反应,中药制剂99例,占比12.7%,中药注射剂63例,占中药制剂的63.6%。结论:应合理使用中药注射剂,加强对中药注射剂的质量监测,避免或减少ADR重复发生。Objective： To understand the characteristics of adverse drug reaction （ADR） in ya＇ an, and promote the rational use of traditional medicine injection in clinic. Methods： The 63 ADR cases of traditional medicine injection had been collected from Jan. 1.2009 to Dem.31.2009 in al 1 of 17 hospitals. All the cases were anlysized in respect of drug species, categories of drugs, typical cases. Results： Of 777 all kinds of ADR cases, 99 cases about traditional medicine preparation accounted for 12.7% and 63 traditional medicine injection accounted for 63.6% in all traditional medicine preparations. Conclusion： Rational use and the good quality of the traditional chinese medicine injection should be emphasized to decrease the occurrence of ADR.

关 键 词：中药注射剂 药品不良反应 药品评价 

分 类 号：R286[医药卫生—中药学]